CCM
ABBV icon

Cox Capital Management’s AbbVie ABBV Stock Holding History

Cox Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.18M Buy
+12,640
New +$2.72M 1.77% 18
2024
Q3 		– Sell
-8,777
Closed -$1.51M – 67
2024
Q2 		$1.51M Sell
8,777
-765
-8% -$127K 0.91% 42
2024
Q1 		$1.74M Sell
9,542
-532
-5% -$91.7K 1.07% 41
2023
Q4 		$1.56M Sell
10,074
-529
-5% -$77.1K 1.02% 40
2023
Q3 		$1.58M Buy
10,603
+819
+8% +$120K 1.11% 39
2023
Q2 		$1.32M Sell
9,784
-492
-5% -$72.1K 0.97% 42
2023
Q1 		$1.64M Sell
10,276
-9,605
-48% -$1.47M 1.18% 40
2022
Q4 		$3.21M Buy
19,881
+663
+3% +$102K 2.09% 14
2022
Q3 		$2.58M Buy
19,218
+211
+1% +$30.3K 1.87% 24
2022
Q2 		$2.91M Buy
19,007
+172
+0.9% +$26.3K 1.99% 20
2022
Q1 		$3.05M Sell
18,835
-4
-0% -$581 1.92% 20
2021
Q4 		$2.55M Sell
18,839
-7,854
-29% -$928K 1.51% 28
2021
Q3 		$2.88M Sell
26,693
-209
-0.8% -$23.9K 1.94% 17
2021
Q2 		$3.03M Sell
26,902
-651
-2% -$73.3K 2.03% 14
2021
Q1 		$2.98M Sell
27,553
-8,720
-24% -$933K 2.07% 13
2020
Q4 		$3.89M Buy
36,273
+1,157
+3% +$111K 2.96% 3
2020
Q3 		$3.08M Buy
35,116
+336
+1% +$31.6K 2.71% 5
2020
Q2 		$3.42M Buy
34,780
+1,264
+4% +$111K 3.37% 2
2020
Q1 		$2.97M Hold
33,516
– – 2.59% 5
2019
Q4 		$2.97M Buy
33,516
+92
+0.3% +$7.64K 2.7% 5
2019
Q3 		$2.53M Buy
33,424
+246
+0.7% +$16.9K 2.47% 10
2019
Q2 		$2.41M Buy
33,178
+10,921
+49% +$858K 2.45% 12
2019
Q1 		$1.79M Buy
22,257
+730
+3% +$59.7K 1.94% 19
2018
Q4 		$1.85M Buy
21,527
+749
+4% +$65.9K 2.17% 15
2018
Q3 		$1.97M Buy
20,778
+571
+3% +$54.1K 2.09% 15
2018
Q2 		$1.87M Buy
+20,207
New +$1.97M 2.26% 13

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Cox Capital Management's ABBV Position: Q2 2026 in Review

Cox Capital Management opened a new position in AbbVie (ABBV) in Q2 2026: 12,640 shares worth $3.18M. The stake represents 1.77% of the portfolio and ranks #18 among its holdings. This is a return to the name: Cox Capital Management previously reported a position in ABBV as recently as Q2 2024.

Cox Capital Management first reported a position in ABBV in Q2 2018 and has held it in 26 quarters since. The position peaked at $3.89M in Q4 2020. 2,012 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cox Capital Management held 12,640 shares of AbbVie worth $3.18M as of Q2 2026.
  • AbbVie was a new Cox Capital Management position in Q2 2026.
  • AbbVie made up 1.77% of Cox Capital Management's portfolio in Q2 2026, its #18 holding.
  • Cox Capital Management first reported a position in AbbVie in Q2 2018 and has held it in 26 quarters since.
  • Cox Capital Management's AbbVie position peaked at $3.89M in Q4 2020.
  • 2,012 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cox Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.